Lineage Cell Therapeutics, Inc. (LCTX) Total assets 2016–2025
Lineage Cell Therapeutics, Inc. (LCTX) total assets at each fiscal year-end, per SEC filings.
$112.6MFY2025 · since FY2016: $142.6M → $112.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $112.6M | -0.6% |
| FY2024 | $113.2M | +12.1% |
| FY2023 | $101.0M | -18.3% |
| FY2022 | $123.7M | -29.2% |
| FY2021 | $174.5M | +61.7% |
| FY2020 | $107.9M | -14.0% |
| FY2019 | $125.5M | +23.4% |
| FY2018 | $101.7M | -41.3% |
| FY2017 | $173.2M | +21.5% |
| FY2016 | $142.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice